XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance, beginning (in shares) at Dec. 31, 2019   37,996,849    
Balance, beginning at Dec. 31, 2019 $ 141,687   $ 441,216 $ (299,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Shares issued upon exercises of stock options (in shares)   376,311    
Shares issued upon exercises of stock options 3,392   3,392  
Shares issued upon vesting of restricted stock units (in shares)   13,000    
Stock-based compensation 683   683  
Net loss (8,642)     (8,642)
Balance, ending (in shares) at Mar. 31, 2020   38,386,160    
Balance, ending at Mar. 31, 2020 137,120   445,291 (308,171)
Balance, beginning (in shares) at Dec. 31, 2019   37,996,849    
Balance, beginning at Dec. 31, 2019 $ 141,687   441,216 (299,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Shares issued upon exercises of stock options (in shares) 475,193      
Net loss $ (18,388)      
Balance, ending (in shares) at Jun. 30, 2020   38,486,542    
Balance, ending at Jun. 30, 2020 128,699   446,616 (317,917)
Balance, beginning (in shares) at Mar. 31, 2020   38,386,160    
Balance, beginning at Mar. 31, 2020 137,120   445,291 (308,171)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Shares issued upon exercises of stock options (in shares)   98,882    
Shares issued upon exercises of stock options 303   303  
Shares issued upon vesting of restricted stock units (in shares)   1,500    
Stock-based compensation 1,022   1,022  
Net loss (9,746)     (9,746)
Balance, ending (in shares) at Jun. 30, 2020   38,486,542    
Balance, ending at Jun. 30, 2020 128,699   446,616 (317,917)
Balance, beginning (in shares) at Dec. 31, 2020   42,196,296    
Balance, beginning at Dec. 31, 2020 191,216   524,022 (332,806)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Shares issued upon exercises of stock options (in shares)   91,737    
Shares issued upon exercises of stock options 282   282  
Shares issued upon vesting of restricted stock units (in shares)   38,000    
Stock-based compensation 2,420   2,420  
Net loss (14,950)     (14,950)
Balance, ending (in shares) at Mar. 31, 2021   42,326,033    
Balance, ending at Mar. 31, 2021 178,968   526,724 (347,756)
Balance, beginning (in shares) at Dec. 31, 2020   42,196,296    
Balance, beginning at Dec. 31, 2020 $ 191,216   524,022 (332,806)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Shares issued upon exercises of stock options (in shares) 116,861      
Net loss $ (30,079)      
Balance, ending (in shares) at Jun. 30, 2021   42,419,129    
Balance, ending at Jun. 30, 2021 167,071   529,956 (362,885)
Balance, beginning (in shares) at Mar. 31, 2021   42,326,033    
Balance, beginning at Mar. 31, 2021 178,968   526,724 (347,756)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Shares issued upon exercises of stock options (in shares)   25,124    
Shares issued upon exercises of stock options 95   95  
Issuance of shares under Employee Stock Purchase Plan (in shares)   22,972    
Issuance of shares under Employee Stock Purchase Plan 219   219  
Shares issued upon vesting of restricted stock units (in shares)   45,000    
Stock-based compensation 2,918   2,918  
Net loss (15,129)     (15,129)
Balance, ending (in shares) at Jun. 30, 2021   42,419,129    
Balance, ending at Jun. 30, 2021 $ 167,071   $ 529,956 $ (362,885)